help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 19, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1957
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/5/1730    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Samuels, M. H.
Right arrow Articles by Janowsky, J. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samuels, M. H.
Right arrow Articles by Janowsky, J. S.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Thyroid

Submitted on September 4, 2007
Accepted on February 8, 2008

Health status, mood and cognition in experimentally-induced subclinical thyrotoxicosis

M. H. Samuels*, K. G. Schuff, N. E. Carlson, P. Carello, and J. S. Janowsky

Division of Endocrinology, Diabetes and Clinical Nutrition (MHS, KGS), Division of Biostatistics (NC), and Department of Behavioral Neurosciences (PC, JJ), Oregon Health & Science University

* To whom correspondence should be addressed. E-mail: samuelsm{at}ohsu.edu.

Objective: To determine whether subclinical thyrotoxicosis alters health status, mood, and/or cognitive function.

Design: Double-blinded, randomized, cross-over study of usual dose L-thyroxine (L-T4) (euthyroid arm) vs. higher dose L-T4 (subclinical thyrotoxicosis arm) in hypothyroid subjects.

Patients: Thirty-three hypothyroid subjects receiving L-T4.

Measurements: Subjects underwent measurements of health status, mood, and cognition: Short Form 36 (SF-36), Profile of Mood States (POMS), and tests of declarative memory (Paragraph Recall, Complex Figure), working memory (N-Back, Subject Ordered Pointing, Digit Span Backwards), and motor learning (Pursuit Rotor). These were repeated after 12 weeks on each of the study arms.

Results: Mean TSH levels decreased from 2.15 to 0.17 mU/L on the subclinical thyrotoxicosis arm (p<.0001), with normal mean free T4 and free T3 levels. The SF-36 physical component summary (PCS) and general health (GH) subscale were slightly worse during the subclinical thyrotoxicosis arm, while the mental health subscale was marginally improved. The POMS confusion, depression, and tension subscales were improved during the subclinical thyrotoxicosis arm. Motor learning was better during the subclinical thyrotoxicosis arm, while declarative and working memory measures did not change. This improvement was related to changes in the SF-36 PCS and POMS tension subscales and free T3 levels.

Conclusions: We found slightly impaired physical health status, but improvements in measures of mental health and mood in L-T4 treated hypothyroid subjects when subclinical thyrotoxocosis was induced in a blinded, randomized fashion. Motor learning was also improved. These findings suggest that thyroid hormone directly affects brain areas responsible for affect and motor function.


Key words: Subclinical thyrotoxicosis • L-thyroxine • Cognition • Mood







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society